{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:38:27Z","timestamp":1791412707471,"version":"4.3.3"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cardiac sarcoidosis (CS) has a poor prognosis related to life-threating arrhythmias and heart failure. Treatment includes anti-inflammatory therapies and implantable pacemaker and\/or cardioverter defibrillator. The presence of cardiac devices and physiologic myocardial glucose uptake are major limitations of both cardiac magnetic resonance and <jats:sup>18<\/jats:sup>F-FDG PET\/CT, reducing their diagnostic value. Somatostatin-based PET\/CT has been proposed to detect active CS. Contrarily to <jats:sup>18<\/jats:sup>F-FDG uptake, which reflects nonspecific leukocyte infiltration, <jats:sup>68<\/jats:sup>Ga-DOTATOC may identify active granulomatosis. Herein, we underline the specificity of <jats:sup>68<\/jats:sup>Ga-DOTATOC PET in challeging clinical situations including refractory CS, and chronic CS in patients with cardiac device, or false-positive <jats:sup>18<\/jats:sup>F-FDG PET\/CT results.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003185","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T21:21:51Z","timestamp":1601500911000},"page":"e416-e418","source":"Crossref","is-referenced-by-count":14,"title":["68Ga-DOTATOC PET for Treatment Efficacy Evaluation of Cardiac Sarcoidosis"],"prefix":"10.1097","volume":"45","author":[{"given":"Alessio","family":"Imperiale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Poindron","sequence":"additional","affiliation":[{"name":"Immunology, University Hospitals of Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Schindler","sequence":"additional","affiliation":[{"name":"Mallinckrodt Institute of Radiology, Division of Nuclear Medicine, Washington University, St Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"El Ghannudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"bib2-20230925","first-page":"1305","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","year":"2014","journal-title":"Heart Rhythm"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11936-017-0539-1","article-title":"Update on treatment in cardiac sarcoidosis","volume":"19","year":"2017","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1540-8167.2008.01417.x","article-title":"The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities","volume":"20","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jcmg.2016.02.029","article-title":"Clinical utility of combined FDG-PET\/MR to assess myocardial disease","volume":"10","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","article-title":"Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations","volume":"28","year":"2014","journal-title":"Ann Nucl Med"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer 68Ga-DOTANOC PET\/CT and 18F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","year":"2016","journal-title":"EJNMMI Res"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:08:53Z","timestamp":1695622133000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003185","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,26]]}}}